Rise in ADHD Cases Among Children in the U.S.

The number of children diagnosed with ADHD has increased in the U.S., with around 6.5 million children ages 3 to 17 having ADHD in 2022, up from 5.4 million in 2016. The rise is attributed to increased awareness of ADHD symptoms, improved diagnosis, and the impact of the Covid-19 pandemic.

Attention-deficit/hyperactivity disorder (ADHD) in Children

ADHD diagnosis rates in children have been increasing in the U.S., with about 1 in 9 children between 3 and 17 diagnosed with the disorder. The pandemic has contributed to the rise in diagnoses due to increased stress, depression, and anxiety among children. Girls are now being diagnosed with ADHD more frequently than before, with the presentation of symptoms differing between boys and girls. Only about half of children diagnosed with ADHD are receiving medication, and there are concerns about a lack of behavioral therapy being provided. Children with ADHD are at increased risk for other disorders and health concerns in adulthood.

Woman's Obsession with the Color Orange

Sheri Scott, a content creator from England, is obsessed with the color orange and incorporates it into every aspect of her life, from her wardrobe to her home decor. Her love for orange stems from feeling her truest self when she dyed her hair that color. Scott's online presence revolves around helping others find their style through dressing in color.

Neurodivergence in the Workplace

Rise in adult neurodivergence diagnoses poses challenges for employers, but understanding and supporting neurodivergent employees can lead to inclusive workplaces and thriving businesses.

Impact of Adderall Shortage on Individuals with ADHD in the US

An analysis suggests that about 1 in 10 people in the US with ADHD who use Adderall or similar drugs have been affected by a shortage, causing a significant drop in prescription fill rates. The shortage has been ongoing since mid-October 2022, impacting both adults and children with ADHD. The shortage has raised concerns about the access to necessary medication and its potential negative impacts on individuals with ADHD.

Impact of ADHD Medication on Reducing Risk of Early Death

A new study published in JAMA found that being treated for ADHD with medication reduces the risk of early death for people with the disorder, particularly deaths due to unnatural causes. The study, conducted in Sweden with over 148,000 participants, suggests that ADHD medication may alleviate symptoms responsible for poor outcomes and reduce fatal accidents.